These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7856324

  • 21. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O, Weiner RD, McEvoy JP.
    Biol Psychiatry; 1997 Jul 15; 42(2):132-7. PubMed ID: 9209730
    [Abstract] [Full Text] [Related]

  • 22. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R, Weizman A, Weizer N, Dorfman-Etrog P, Munitz H.
    Harefuah; 2001 May 15; 140(5):369-73, 456. PubMed ID: 11419053
    [Abstract] [Full Text] [Related]

  • 23. Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients.
    Löffler S, Löffler-Ensgraber M, Fehsel K, Klimke A.
    Int Clin Psychopharmacol; 2010 Mar 15; 25(2):101-6. PubMed ID: 20101184
    [Abstract] [Full Text] [Related]

  • 24. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P, Bartell J, Donenwirth K, Lee S, Torigoe F, Schulz SC.
    Bull Am Acad Psychiatry Law; 1995 Mar 15; 23(4):607-11. PubMed ID: 8639988
    [Abstract] [Full Text] [Related]

  • 25. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
    Thompson PA, Buckley PF, Meltzer HY.
    J Clin Psychopharmacol; 1994 Oct 15; 14(5):344-6. PubMed ID: 7806691
    [Abstract] [Full Text] [Related]

  • 26. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
    Berecz R, Glaub T, Kellermann M, de la Rubia A, Llerena A, Degrell I.
    Pharmacopsychiatry; 2000 Jan 15; 33(1):42-4. PubMed ID: 10721883
    [Abstract] [Full Text] [Related]

  • 27. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.
    Psychiatry Res; 2009 Jul 30; 168(2):110-8. PubMed ID: 19501918
    [Abstract] [Full Text] [Related]

  • 28. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
    Brown AS, Gewirtz G, Harkavy-Friedman J, Cooper T, Brébion G, Amador XF, Malaspina D, Gorman JM.
    Neuropsychopharmacology; 1997 Nov 30; 17(5):317-25. PubMed ID: 9348547
    [Abstract] [Full Text] [Related]

  • 29. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment.
    Cai HL, Fang PF, Li HD, Zhang XH, Hu L, Yang W, Ye HS.
    Psychiatry Res; 2011 Jul 30; 188(2):197-202. PubMed ID: 21146875
    [Abstract] [Full Text] [Related]

  • 30. [Clinical effects of clozapine: effect on negative symptoms].
    Llorca PM, Lançon C, Auquier P, Bougerol T.
    Encephale; 1996 Jul 30; 22(4):287-92. PubMed ID: 9035984
    [Abstract] [Full Text] [Related]

  • 31. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM, Smith L.
    Acta Psychiatr Scand; 2009 Jun 30; 119(6):419-25. PubMed ID: 19245679
    [Abstract] [Full Text] [Related]

  • 32. Clinical response to clozapine treatment of 11 chronic patients in a state psychiatric hospital.
    Herman M.
    Aust N Z J Ment Health Nurs; 1997 Sep 30; 6(3):129-33. PubMed ID: 9384012
    [Abstract] [Full Text] [Related]

  • 33. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
    Delle Chiaie R, Salviati M, Fiorentini S, Biondi M.
    Exp Clin Psychopharmacol; 2007 Dec 30; 15(6):563-8. PubMed ID: 18179309
    [Abstract] [Full Text] [Related]

  • 34. Different serine and glycine metabolism in patients with schizophrenia receiving clozapine.
    Hons J, Vasatova M, Cermakova E, Doubek P, Libiger J.
    J Psychiatr Res; 2012 Jun 30; 46(6):811-8. PubMed ID: 22502820
    [Abstract] [Full Text] [Related]

  • 35. [Value of neuroleptic therapy in the self assessment of schizophrenic patients].
    Heim M.
    Psychiatr Neurol Med Psychol (Leipz); 1987 Aug 30; 39(8):487-91. PubMed ID: 3685210
    [Abstract] [Full Text] [Related]

  • 36. Plasma clozapine levels and clinical benefit.
    Greenberg WM.
    J Clin Psychiatry; 1995 Nov 30; 56(11):535-6. PubMed ID: 7592511
    [No Abstract] [Full Text] [Related]

  • 37. [Status-dependent neurochemical parameters in schizophrenic and affective diseases].
    Gross G, Huber G, Klosterkötter J, Rao ML, Linz M.
    Fortschr Neurol Psychiatr; 1990 Apr 30; 58(4):154-60. PubMed ID: 1972372
    [Abstract] [Full Text] [Related]

  • 38. Do anticonvulsants hinder clozapine treatment?
    Wilson WH.
    Biol Psychiatry; 1995 Jan 15; 37(2):132-3. PubMed ID: 7718678
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study.
    Alphs LD, Lee HS.
    J Clin Psychiatry; 1991 Aug 15; 52(8):346-8. PubMed ID: 1869497
    [Abstract] [Full Text] [Related]

  • 40. Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
    Lee J, Takeuchi H, Fervaha G, Bhaloo A, Powell V, Remington G.
    Eur Neuropsychopharmacol; 2014 Oct 15; 24(10):1622-9. PubMed ID: 25156578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.